June 2, 2026
Headlines

Antibiotics

Wockhardt’s New Antibiotic Breakthrough: A Milestone for Indian Pharmaceutical Innovation

Business News Desk03 mins mins

A Strategic Validation for Wockhardt Mumbai-based pharmaceutical giant Wockhardt Ltd. secured a major milestone this week as the U.S. Food and Drug Administration (FDA) granted approval for Zaynich, an innovative antibiotic designed to treat complicated urinary tract infections (cUTI). This regulatory clearance marks only the second time an Indian-developed drug has received such an endorsement,…

Read More
Wockhardt Bets on Self-Commercialization to Capture Value from Breakthrough Antibiotic Zaynich

Wockhardt Bets on Self-Commercialization to Capture Value from Breakthrough Antibiotic Zaynich

Business News Desk03 mins mins

Strategic Shift in Market Entry Mumbai-based pharmaceutical firm Wockhardt has officially decided to self-commercialize its newly approved antibiotic, Zaynich, opting against traditional global licensing deals to retain maximum value. Following recent marketing authorization from the Central Drugs Standard Control Organisation (CDSCO) and significant regulatory progress with the U.S. Food and Drug Administration (USFDA), the company…

Read More